Member Info for VanVan

Another significant RNS. Are we on a roll? Keep them coming. How about a Tavsan licence? Some indicating gold has bottomed as well, with potential to go well into the $2000’s this year. I think the jury is still out on that one.

Up another 28% in USA . 14p equivalent? Another big day tomorrow??

You can take a horse to water but can't force him to drink I guess!

Lets not forget its not just the combined total JORC resource of 2.1m ozs of gold. there is also a lot of silver and Copper in Cyprus.
And importantly at Salinbas we have a JORC Exploration Target of up to a further 2.7m ozs gold and 16.1 m ozs of silver with potential for further resource extensions.
I'm looking forward to the fully funded drill programme at Salinbas, but also at Tavsan (drilling starts Spring) and at Kiziltepe where there is 4000/5000 m - 2 Rig diamond drill programme underway to test vein extensions at Arzu South and North, Derya & Banu. Basically working both ends of the hill moving towards the centre.
In his words in the RNS Kerim says: "making our J.V. one of the most significant gold mining ventures in Turkey". If you were to research other Turkish mines and their value I'm sure this would make ours look totally unrepresentative.

Details of the amount and timing have not yet been released.
There will be a virtual General Meeting on 26th Feb to get shareholders to approve the legal aspects - cancellation of share premium account etc.
There then has to be Court approval. So it will take a few months.
Go on the Website to read the Circular to Shareholders and Q & A's from the Co.
Some think it could be between 0.7p & 1p per share!

Can you believe it? We are there. It is done.
Well done Kerim and team.
Now let’s get cracking.
Ariana with Attitude.
Well done all those that kept the faith .

I believe Coinsilium operates on these two markets.
1.OTQCB - CINGF
2. AQUIF - COIN - this is the U.K. market.
The OTQCB market price was up 85% yesterday. Is this based in the US. The trading hours are normal US ones I presume?
There seems a disconnect in the prices at the moment - circa 9p versus 11p

Great interview but the sound keeps stopping and I miss important words. Does anyone know why that would be? Listening on my iPhone. Don’t normally listen to BBC but on an occasion like this were it is a must, given I’m paying a compulsory license fee and it doesn’t work, I’m none too pleased.

Ray in his excellent post 3034, I think is suggesting we are at the foothills of value mountain. This unexpected but beneficial diversion into a Covid vaccine has enabled us to accelerate the proof of concept for our core research work, which in turn will widen awareness of our break through science and probably attract wanton bees to our honey pot.The future for Scancell has surely never been so exciting. Have I got that right Ray?

In his Bulletin Hero’s he sees 50p by end of Feb or perhaps end of March. If a big name comes sniffing we can forget conventional charts however imo. Hold fast.

Suddenly after years in the shade, everyone can’t get enough of us.

I’ve been invested for about 4/5 years. Attended one AGM. Meet the delightful Lindy and watched patiently. I was always under the impression that we were under the radar but can’t believe the number of recent postings, even on a Sunday. Obviously got that wrong.

On Twitter Telegraph? Exclusive: 'Universal vaccine' that can conquer all variants could be available within a year thanks to British scientists. Scancell is targeting a protein in the core of the virus called the nucleocapsid or “N” protein, alongside the spike protein.

Nice Q & A's on the Coy's website. What's not clear about this?
The potential buy-back of the Company’s shares is primarily focussed on the occasional purchase of employee shares to assist them with what would have been an otherwise difficult process of realising their shares received via the Company’s incentive scheme. It is not intended for the wholesale purchase of the Company’s shares via market purchase or the purchase of director’s share options.

he assay results are expected in the coming weeks

“Nobody saw this one coming, nobody saw it spreading

‘For 30 years, infectious diseases were the most unloved Cinderella industry in pharma’

‘Ihave spent my life hating debt’

so fast but vision with hindsight, they can see why it spread, but we have been so, so lucky.”

Open Orphan is, he says, “riding the wave and I don’t see any crash coming just yet”.

For example, the company is now trialling a Covid nasal spray vaccine from US company Codagenix.

For the last 30 years infectious diseases “were the most unloved Cinderella industry in the pharma industry…nobody wanted to know.” he says.

However, Friel does not expect to see a pandemic like this again in our lifetime thanks to the increased spending that will go into healthcare.

“Unfortunately, Ireland and the rest of Europe is going to be about six months behind Britain because of what Britain is doing – and I think it’s absolutely sensational, I know it is popular to beat up Boris [Johnson] and beat up the UK Brexiters – but what they have done is absolutely entrepreneurial.”

The UK has vaccinated more people than any large nation.

“Britain’s pandemic will be over by early summer. The rest of Europe because we didn’t get [the vaccine] approved in time, we will be paddling that boat until the Autumn time,” says Friel who spends most of his time in London.

He has come a long way since running the family business in Donegal aged just 16 after illness hospitalised his father and he spent his time trying to “keep the bank manager off my parents back”.

His career has taken in the Irish Software Association, Merrion Stockbrokers, Fastnet Oil and Gas, Amryt Pharma, Raglan Capital, and now as executive chairman of Open Orphan.

Those early days in Donegal have made him averse to debt and the run-up to the 2008 economic crash was the only time in his working life when he felt “really poor”.

“For the two, three, four years up to 2008 I kept wondering how are all these people affording houses in Portugal, how are they were affording apartments in Dubai and all these places and all driving Range Rovers, and I was thinking ‘I’m working about 25 years I should be richer’, but I didn’t realise,” Friel says.

“I have spent my life hating debt because it f**ked up my childhood.”

Now, he is the father of three “mad craic” children. “I think everybody should re-invent every three, four, five years, and how do you re-invent? You read the books, watch a few videos at night.”

Scotty on ADVFN has manage to post more of the article on ADVFN and has agreed I can copy it across to here. It really is a great read in more ways than one.
********************
Scotty says :- Didn't realise there was more to follow on the article I posted yesterday, so here it is

https://www.pressreader.com/
“That would be my fourth successful IPO, a record for any person in Ireland.”
Open Orphan’s time has come thanks in large part to the defining health emergency of our time, the kind of pandemic that has not been seen in a century and the first one of its scale to be confronted by modern health systems, in the rich world at least.
“Governments now are spending – and that’s why Open Orphan is so lucky – they are spending tens of millions around the world developing and looking at where will the next pandemic come from. Let’s get the first line of defence, antivirals,” he says.

“Going forward, we are really busy working on next-generation vaccines.”

Nine vaccines have so far been approved under various regulatory regimes for use against Covid-19, and many others are in development.

“We are booked out almost years ahead, big pharma is ringing us up ‘can you run a trial in an RSV [respiratory syncytial virus] vaccine?’. Yep, no problem.”

While some have been surprised at how quickly pharmaceutical companies were able to develop vaccines, Friel says that “the scientific world has taken all their artificial intelligence, all their genetic work and thrown it all at it”.

Even as scientists fret over new Covid variants, Friel thinks that once the vaccines are fully rolled out it is “game over” for the current pandemic and that attention will then turn to finding a way to wipe out influenza.

He points to the relatively low spend on influenza research, a figure he puts at “no more than a couple of hundred million” annually.

“Do you know how much was spent trying to find a Covid cure? The last time I checked it was in the in the region of between $300bn and $400bn, so it’s a wall of money, and guess what? Covid is cured,” he says.

“And with influenza, we know at the moment we’re booked out with influenza studies. So there is going to be a wall of money thrown at influenza by the UN, WHO [World Health Organisation], governments, and like everything in life, throw enough money at it and it will be solved. That’s one beauty of it, as soon as Covid is sorted and it’s nearly there, they will turn the big guns and the big money [at influenza].”

The lack of spending was part of the reason the virus spread so rapidly around the world. A pandemic, he says is “a bit like a bushfire. It goes whoosh”.

“It was very contagious, but bear in mind there was virtually no money spent on antivirals for 30 years, so when this thing popped its head up… there was a fire in the house and there were no fire extinguishers,” Friel says.

Part 2 to follow.

Nailed it. Well done YJ & Co.

Eskers showing article from Irish Independent on Twitter today
" The greatest gold rush in infectious diseases is just starting ....we have every capability to become a billion-dollar company...Friel is considering spinning some of the non core Pharma assets into a separate listing on the Stock Exchange"
independent.ie

There has been quite a bit of debate on ADVFN regarding Resolution 3 that will allow the Directors authority to buy back up to 5% of the issued ordinary shares into Treasury.
I have managed to speak with Yellow Jersey this afternoon concerning this and we talked through the valid points that have been raised. They are aware of this discussion and have kindly confirmed that the company will clarify this for all shareholders, probably later this week. So please watch this space